July 9, 2020|Access to Medicines, COVID-19Biden’s Commitment to Global Sharing of COVID-19 Vaccine Technology is a Step in the Right Direction, Must be Followed by Concrete Plans to Dismantle Dangerous Healthcare NationalismIn a conversation with healthcare activist Ady Barkan, Vice President Joe Biden, the presumptive Democratic nominee for U.S. president, committed to sharing COVID-19 vaccine technologies and ensuring patents do not stand in the way of other countries accessing life-saving vaccines…
May 29, 2020|Access to Medicines, COVID-19Statement from Health GAP on today’s “Solidarity Call to Action” in support of the WHO COVID-19 Technology Access PoolWhen governments don’t stand up to Big Pharma, disaster ensues. Twenty years ago, millions of poor people in sub Saharan Africa were dying preventable deaths from AIDS because of pharma’s price gouging. International shame and pressure brought Big Pharma to…
May 21, 2020|Access to Medicines, COVID-19More Than 80 Academics, Researchers, and Teachers Call on President Ramaphosa to Fix the Patent LawsThe letter reproduced below was sent to President Cyril Ramaphosa on 19 May 2020 by more than 80 leading academics, researchers and teachers in South Africa. They urge the President to urgently reform South Africa’s patent laws and take further…
May 18, 2020|Access to Medicines, COVID-19South Africa’s patent laws threaten access to future COVID-19 medicinesContact: Lotti Rutter (Health GAP) | lotti@healthap.org | +27 82 065 5842 Ntsiki Mpulo (SECTION27) | mpulo@section27.org.za | +27 82 782 7143 Ngqabutho Mpofu (TAC) | ngqabutho.mpofu@tac.org.za | +27 72 225 9675 (Johannesburg) — In a letter to President Cyril Ramaphosa…
May 4, 2020|Access to Medicines, COVID-19Funding Raised at Coronavirus Global Response Summit Must Come with “Strings Attached” to Ensure Access for AllAs a pledging conference for the World Health Organization’s Access to COVID-19 Tools (ACT) Accelerator kicks off today during the Coronavirus Global Response Summit, hosted by the European Commission, Germany, France, United Kingdom, Norway and Saudi Arabia, activists called for…
April 23, 2020|Access to MedicinesActivists Critique Johnson & Johnson’s Framework for “Non-Profit” Pricing and Single-Source Manufacturing of COVID-19 Vaccine CandidateJohnson & Johnson held its virtual shareholder meeting today – the first shareholder meeting of a company with a candidate product since the height of the COVID-19 outbreak. J&J has made headlines recently with its announcement that it intends to sell its…
April 16, 2020|Access to Medicines, Funding the Fight, Health JusticeGlobal Health Organizations Denounce Trump’s Decision to Pull Commitments to WHO during COVID-19 PandemicAVAC, Health GAP, Knowledge Ecology International (KEI), and Treatment Action Group (TAG) strongly condemn the Trump Administration’s decision to halt funding to the World Health Organization (WHO) in the midst of the urgent COVID-19 global health crisis. “In a time…
April 3, 2020|Access to MedicinesAnalysis & Comment on Johnson & Johnson COVID-19 Vaccine Candidate Pricing and Manufacturing Capacity Johnson & Johnson has announced that it intends to sell its COVID-19 vaccine candidate for 10 euros a dose, depending on production costs and volume. This would be a concessionary, no-profit price. Johnson & Johnson further reported that it might…
March 27, 2020|Access to MedicinesWith Access to Life-Saving COVID-19 Medicines and Diagnostics at Risk, Health GAP Joins the Call for Creation of Emergency Technology IP Pool Benefiting All CountriesAs the world races to develop treatments, a vaccine, and improved diagnostics for COVID-19, there are mounting concerns that life-saving medical technologies will be priced out of reach for millions worldwide, particularly those in countries where health systems have been…
February 5, 2020|Access to Medicines, Funding the Fight, Health JusticeStatement in Response to President Trump’s 2020 State of the Union AddressOn Ending the AIDS Epidemic: “President Trump took a victory lap tonight for his year-old plan to end the domestic HIV epidemic, but his record deserves no praise. Three years into the job, Trump still has not articulated a plan…
